Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Standard Biotools (LAB) over the last 4 years, with Q3 2025 value amounting to $2.5 million.

  • Standard Biotools' Other Accumulated Expenses fell 6562.97% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 6562.97%. This contributed to the annual value of $4.7 million for FY2024, which is 1549.71% up from last year.
  • According to the latest figures from Q3 2025, Standard Biotools' Other Accumulated Expenses is $2.5 million, which was down 6562.97% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Other Accumulated Expenses registered a high of $7.3 million during Q3 2024, and its lowest value of $714000.0 during Q3 2023.
  • In the last 4 years, Standard Biotools' Other Accumulated Expenses had a median value of $4.3 million in 2023 and averaged $3.9 million.
  • Per our database at Business Quant, Standard Biotools' Other Accumulated Expenses soared by 91750.7% in 2024 and then crashed by 8363.45% in 2025.
  • Quarter analysis of 4 years shows Standard Biotools' Other Accumulated Expenses stood at $913000.0 in 2022, then soared by 341.73% to $4.0 million in 2023, then grew by 15.5% to $4.7 million in 2024, then plummeted by 46.39% to $2.5 million in 2025.
  • Its Other Accumulated Expenses was $2.5 million in Q3 2025, compared to $1.1 million in Q2 2025 and $4.6 million in Q1 2025.